Dr. Sharad Ramanathan's lab at Harvard University focuses on understanding how specific cells in the human brain, called astrocytes, develop and function. They create advanced models of the human brain using stem cells to explore the genetic and environmental factors that influence brain development. Ultimately, this research aims to improve our understanding of various brain diseases and may help develop new treatments.

Dr. Wade G. Regehr's lab at Harvard Medical School studies the complex circuitry of the cerebellum, focusing on how different types of neurons contribute to its functions. The lab examines how these neurons process signals and influence behaviors, such as motor control and social interactions. By upgrading our understanding of cerebellar circuits, the research aims to shed light on cerebellar disorders and their effects on neurological health.

Dr. Eric J. Rubin's lab at Harvard University focuses on understanding and addressing the challenges posed by non-tuberculous mycobacteria (NTMs), which are responsible for difficult-to-treat chronic infections. The lab investigates the molecular mechanisms that lead to inherent drug resistance in these pathogens and aims to identify new strategies to enhance the effectiveness of existing antibiotics and develop novel treatment options. By utilizing advanced genetic techniques and culture models, the team seeks to uncover potential therapeutic targets that could facilitate better management of NTM infections.

David Z Rudner's lab at Harvard Medical School studies bacteria, particularly a type called Bacillus subtilis. They focus on how these bacteria grow, differentiate, and how they handle their chromosomes and cell walls during these processes. Understanding these fundamental mechanisms may lead to new treatments for bacterial infections and insights into cancer-related cell division failures.

Dr. Bernardo L. Sabatini's lab focuses on understanding how the brain's neurotransmitter signals, especially dopamine, influence decision-making and behavior. The research investigates how different types of dopamine signaling operate, impacting learning and memory, as well as exploring the complexities of synaptic transmission in the brain. By studying these processes in mice, the lab aims to uncover mechanisms related to neuropsychiatric diseases and improve our understanding of brain function.

Dr. Aravinthan D. Samuel's lab focuses on understanding how the brain adapts behavior based on environmental cues, using the simple model organism C. elegans. The research delves into the neural circuits that drive mating behaviors adapted to different environments, exploring changes at the synaptic and cellular levels. Additionally, the lab is developing innovative imaging techniques for mapping brain connections more rapidly and affordably, making advanced connectomics accessible to a wider range of researchers.

Dr. Kevin Struhl's lab at Harvard Medical School focuses on understanding how genes are expressed in eukaryotic organisms, linking these mechanisms to human diseases. The research primarily investigates the processes of mRNA production, stability, and how specific RNA sequences affect gene regulation. Through innovative experiments and techniques, the lab aims to uncover the fundamental roles of transcription and mRNA processing in genetics and biological function.

Dr. Abigail Sloan Devlin's lab at Harvard Medical School focuses on understanding the role of microbiome-derived sulfated metabolites in human health. Their research investigates how these compounds, produced by gut bacteria, can influence immune responses and potentially lead to new therapies for diseases like autoimmune disorders. By combining analytical chemistry and biological studies, the lab aims to uncover the identity and function of these metabolites and the bacteria that produce them.

Dr. Eugene I Shakhnovich's lab at Harvard University focuses on understanding how bacteria adapt to challenges like antibiotic stress through rigorous experimental and theoretical approaches. By developing models that map the relationship between molecular properties and evolutionary fitness, the lab aims to predict how pathogens evolve and resist treatment. This research could lead to innovative strategies for combating antibiotic resistance and improving therapeutic interventions.

Dr. Andrew G. Myers' lab at Harvard University focuses on developing new antibiotics to combat the growing problem of antibiotic resistance, particularly against multi-drug resistant bacteria. The research involves synthesizing innovative antibiotic compounds and studying their mechanisms of action to combat pathogens that pose significant threats to public health. This work aims to deliver novel antibiotic options that can effectively treat serious bacterial infections that have become resistant to existing drugs.

Dr. Roger L. Shapiro's lab at Harvard focuses on improving treatment strategies for children and pregnant women living with HIV. Their research emphasizes the use of broadly neutralizing antibodies as potential alternatives to traditional antiretroviral therapy (ART), with aims to enhance safety and effectiveness during sensitive developmental periods. The lab conducts clinical trials in Botswana to explore innovative approaches, including the safe interruption of ART, and addresses critical questions concerning treatment during pregnancy and infancy.

Dr. Chenghua Gu's lab at Harvard Medical School focuses on understanding the blood-brain barrier (BBB), which protects the brain by regulating what substances can enter from the bloodstream. The lab investigates the molecular mechanisms that maintain this barrier and how it can be manipulated for drug delivery, particularly in the context of neurological disorders like Alzheimer's and Parkinson's disease. By combining genetics, imaging, and biochemical approaches, the lab aims to develop new therapies to better treat brain-related health issues.

Karen M. Emmons' research lab focuses on improving cancer outcomes by strengthening community health centers and enhancing their capacity to provide evidence-based screenings and tobacco treatments. The lab explores how to build social connections within communities to facilitate better health access and outcomes, as well as utilizing technology to support these advancements. Through partnerships and community engagement, they aim to develop solutions that are sustainable and scalable.

Dr. Jeff Lichtman's lab focuses on mapping the brain's intricate connections at the level of individual synapses, particularly in the mouse hippocampus, which plays a crucial role in memory and navigation. By using advanced imaging techniques, the lab aims to generate a comprehensive brain map that will enhance our understanding of how brain circuits function and how they may malfunction in diseases like Alzheimer’s. The research also emphasizes involving students in hands-on scientific processes to foster education and discovery.

Dr. Sichen Shao's lab at Harvard Medical School focuses on understanding how red blood cells develop and function by studying a special enzyme called UBE2O. This enzyme helps to manage the proteins needed to form healthy red blood cells, which are essential for carrying oxygen throughout the body. By exploring the mechanisms behind protein quality control and degradation, the lab aims to uncover important factors related to blood disorders and potential new therapies.

Dr. Karen L. Adelman's lab at Harvard Medical School focuses on understanding how the Integrator complex regulates gene expression in response to various signals. This work is crucial for deciphering mechanisms underlying normal development and diseases that arise from dysfunctions in these processes, such as cancer and developmental disorders. The research provides insights into how cells respond to stress and environmental cues by controlling the production of messenger RNA.

Dr. Jun R. Huh's lab at Harvard Medical School studies how pregnancy-related immune changes affect brain development in fetuses, particularly focusing on the differences between male and female brains. The research aims to understand why neurodevelopmental disorders, such as autism spectrum disorder, are more common in males and how maternal immune factors play a role in shaping fetal brain vulnerability to stress. By examining the mechanisms involved, the lab aims to provide insights that could lead to better interventions for these disorders.

Dr. Marcia Haigis's lab at Harvard Medical School focuses on understanding how cellular metabolism drives the initiation and progression of colorectal cancer (CRC). The research particularly investigates the role of a protein family called sirtuins, specifically SIRT4, in regulating metabolic changes associated with cancer and chemotherapy resistance. By exploring how SIRT4 influences cell growth and survival through metabolic pathways, the lab aims to pave the way for new and effective cancer therapies.

Dr. Richard T Lee's lab at Harvard University focuses on understanding the role of mitochondria and specific proteins in heart function and heart diseases, particularly cardiomyopathy. The lab uses advanced gene editing techniques to investigate mitochondrial DNA mutations and their effects on heart muscle cells, as well as the signaling roles of growth differentiation factors in heart health. This research aims to uncover crucial mechanisms that could lead to new therapies for mitochondrial diseases and heart-related conditions.

Dr. Amanda Joy Whipple's research lab at Harvard University focuses on understanding how a specific molecular factor, SNORD116, contributes to Prader-Willi syndrome, a complex neurodevelopmental disorder. Her team is investigating the role of SNORD116 in the biology of neuronal ribosomes, which are essential for protein synthesis in brain cells. By exploring the interactions of SNORD116 and its implications for brain function, the lab aims to uncover potential therapeutic strategies for correcting the unique challenges associated with Prader-Willi syndrome and similar disorders.